Context Historical Income Statement
| CNTX Stock | USD 1.39 0.05 3.47% |
Historical analysis of Context Therapeutics income statement accounts such as Selling General Administrative of 9.1 M, Total Revenue of 0.0 or Research Development of 8.9 M can show how well Context Therapeutics performed in making a profits. Evaluating Context Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Context Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Context Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Context Therapeutics is a good buy for the upcoming year.
Context |
About Context Income Statement Analysis
Context Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Context Therapeutics shareholders. The income statement also shows Context investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Context Therapeutics Income Statement Chart
Add Fundamental
Cost Of Revenue
Cost of Revenue is found on Context Therapeutics income statement and represents the costs associated with goods and services Context Therapeutics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Net Income Applicable To Common Shares
The net income that remains after preferred dividends have been deducted, available to common shareholders.Most accounts from Context Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Context Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Context Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Context Stock please use our How to Invest in Context Therapeutics guide.At this time, Context Therapeutics' Selling General Administrative is fairly stable compared to the past year. Net Interest Income is likely to rise to about 1.3 M in 2024, whereas Interest Expense is likely to drop slightly above 435.1 K in 2024.
Context Therapeutics income statement Correlations
Click cells to compare fundamentals
Context Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Context Stock Analysis
When running Context Therapeutics' price analysis, check to measure Context Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Context Therapeutics is operating at the current time. Most of Context Therapeutics' value examination focuses on studying past and present price action to predict the probability of Context Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Context Therapeutics' price. Additionally, you may evaluate how the addition of Context Therapeutics to your portfolios can decrease your overall portfolio volatility.